BCR antibody
Quick Overview for BCR antibody (ABIN7137944)
Target
See all BCR AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- BCR (Ab-177) Antibody
-
Cross-Reactivity
- Mouse
-
Purification
- Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
Immunogen
- Peptide sequence around aa. 175~179 (P-F-Y-V-N) derived from Human Bcr.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- BCR (Breakpoint Cluster Region (BCR))
-
Alternative Name
- BCR
-
Background
-
Background: GTPase-activating protein for RAC1 and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. Displays serine/threonine kinase activity.
Sattler M, et al. Mol Cell Biol. 1999 Nov, 19(11): 7473-7480.
Li S et al. EMBO J. 2001 Dec 3, 20(23): 6793-6804.
Million RP, et,al. Mol Cell Biol. 2004 Jun, 24(11): 4685-4695.
Malcolm A. Meyn, et al. . Biol. Chem., Oct 2006, 281: 30907Aliases: ALL antibody, bcr antibody, BCR/ABL FUSION GENE, INCLUDED antibody, BCR/FGFR1 chimera protein antibody, BCR/FGFR1 FUSION GENE, INCLUDED antibody, BCR/PDGFRA FUSION GENE, INCLUDED antibody, BCR_HUMAN antibody, BCR1 antibody, Breakpoint cluster region antibody, Breakpoint cluster region protein antibody, CML antibody, D22S11 antibody, D22S662 antibody, FGFR1/BCR chimera protein antibody, PHL antibody, Renal carcinoma antigen NY-REN-26 antibody
-
UniProt
- P11274
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
Target
-